title: Does tenofovir increase efavirenz hepatotoxicity?
authors.forename: Emanuela
authors.initials: E
authors.lastname: Lattuada
authors.forename: Massimiliano
authors.initials: M
authors.lastname: Lanzafame
authors.forename: Giada
authors.initials: G
authors.lastname: Carolo
authors.forename: Martina
authors.initials: M
authors.lastname: Gottardi
authors.forename: Ercole
authors.initials: E
authors.lastname: Concia
authors.forename: Sandro
authors.initials: S
authors.lastname: Vento
mesh_terms: D000225:Adenine / Q000009:adverse effects / Q000031:analogs & derivatives*; D000328:Adult; D000480:Alkynes; D019380:Anti-HIV Agents / Q000009:adverse effects*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D048588:Benzoxazines / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D003521:Cyclopropanes; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D063065:Organophosphonates / Q000009:adverse effects*; D000068698:Tenofovir
chemical_list: D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D063065:Organophosphonates; D000068698:Tenofovir; D000225:Adenine; C098320:efavirenz